David Grossman

Stock Analyst at Stifel Nicolaus

(2.22)
# 2,872
Out of 4,396 analysts
603
Total ratings
46.6%
Success rate
0.4%
Average return

Stocks Rated by David Grossman

Hinge Health
Jun 8, 2026
Maintained: Buy
Price Target: $67
Current: $62.78
Upside: +6.72%
ExlService Holdings
Jun 5, 2026
Maintained: Buy
Price Target: $46
Current: $29.71
Upside: +54.83%
TriNet Group
Jun 5, 2026
Maintained: Buy
Price Target: $70
Current: $47.82
Upside: +46.38%
Veeva Systems
Jun 4, 2026
Rated: Buy
Price Target: $245$230
Current: $167.68
Upside: +37.17%
Accenture
Jun 3, 2026
Rated: Buy
Price Target: $315$270
Current: $173.47
Upside: +55.65%
International Business Machines
May 22, 2026
Maintained: Buy
Price Target: $290
Current: $277.49
Upside: +4.51%
DarioHealth
May 15, 2026
Maintained: Buy
Price Target: $10
Current: $7.53
Upside: +32.80%
OptimizeRx
May 13, 2026
Rated: Buy
Price Target: $17$14
Current: $5.07
Upside: +176.13%
Health Catalyst
May 12, 2026
Maintained: Hold
Price Target: $2
Current: $1.71
Upside: +16.96%
DocGo
May 12, 2026
Maintained: Buy
Price Target: $2.5
Current: $0.5791
Upside: +331.70%
Maintained: Buy
Price Target: $246$200
Current: $95.65
Upside: +109.10%
Rated: Hold
Price Target: $14$12
Current: $8.85
Upside: +35.59%
Maintained: Hold
Price Target: $5$6.5
Current: $8.50
Upside: -23.53%
Maintained: Hold
Price Target: $270$240
Current: $231.17
Upside: +3.82%
Maintained: Hold
Price Target: $6$5.5
Current: $6.93
Upside: -20.63%
Maintained: Hold
Price Target: $17$15
Current: $12.24
Upside: +22.55%
Maintained: Hold
Price Target: $105
Current: $100.28
Upside: +4.71%
Maintained: Buy
Price Target: $5$3
Current: $0.8505
Upside: +252.73%
Reiterated: Buy
Price Target: $58
Current: $120.36
Upside: n/a